College of Medicine
November 22, 2021
UAMS Researchers Receive $1.5 Million to Study Impact of Maternal Diabetes on Fetal Neurodevelopment
![Members of the interdisciplinary research team include, (l-r): Heather Moody, RN, Eric Siegel, M.S., Stefanie Kennon-McGill, Ph.D., Hari Eswaran, Ph.D., Shannon Rose, Ph.D., Luis Mercado, Ph.D., Diana Escalona-Vargas, Ph.D., and Debopam Samanta, M.D.](https://news.uams.edu/wp-content/uploads/2021/11/Eswaran-research-team-150x150.jpg)
LITTLE ROCK —Researchers at the University of Arkansas for Medical Sciences (UAMS) hope to gain important insights about fetal neurodevelopment in a new study with diabetic pregnant mothers. Funded by a four-year, $1.5 million grant from the National Institutes of Health (NIH), the first study of its kind will use advanced fetal monitoring techniques and…
November 16, 2021
Epileptologist Harshad Ladha, M.D., Joins UAMS Department of Neurology
![Harshad Ladha, M.D., in white coat](https://news.uams.edu/wp-content/uploads/2021/11/Ladha_Harshad-Shrigopal_wide-150x150.jpg)
Harshad Ladha, M.D., an epileptologist, recently joined the University of Arkansas for Medical Sciences (UAMS)’ Level 4 Comprehensive Epilepsy Center as an assistant professor in the Department of Neurology. Ladha comes to UAMS from Emory University School of Medicine in Atlanta, Georgia, where he was a clinical neurophysiology fellow and then an epilepsy fellow. Earlier,…
Epilepsy Experts Share Updates on Condition during UAMS Symposium
![Harshad Ladha, M.D., used graphics to illustrate his presentation.](https://news.uams.edu/wp-content/uploads/2021/11/Ladha-brain-2-copy-150x150.png)
Six multidisciplinary experts on epilepsy shared the latest updates on the neurological condition that affects over 65 million people worldwide, including 3.4 million in the United States, in a virtual epilepsy symposium hosted Nov. 6 by the University of Arkansas for Medical Sciences (UAMS). The Third Annual Epilepsy Symposium consisted of segments focused on pediatric…
November 5, 2021
Insall Traveling Fellows Visit UAMS for Fourth Consecutive Year
![2021 Insall Fellows Martin Faschingbauer, M.D., Sumon Nandi, M.D., and J. Ryan Martin, M.D. (center) shown with UAMS hip and knee surgeons Jeffery Stambough, M.D., Simon Mears, M.D., Ph.D. Lowry Barnes, M.D., and Ben Stronach, M.D.](https://news.uams.edu/wp-content/uploads/2021/11/Insall-Small-Group-Photo2-150x150.jpg)
In October, the University of Arkansas for Medical Sciences (UAMS) welcomed the 2021 John N. Insall Traveling Fellows for a two-day program hosted by the College of Medicine’s Department of Orthopaedic Surgery.
November 2, 2021
UAMS Selects Laura Dunn, M.D., to Lead Department of Psychiatry, Psychiatric Research Institute
![Laura B. Dunn, M.D., will be joining UAMS on Feb. 1, 2022, as the as the next chair of the Department of Psychiatry in the UAMS College of Medicine and director of the Psychiatric Research Institute.](https://news.uams.edu/wp-content/uploads/2021/11/Laura-Dunn-for-posting-150x150.jpg)
LITTLE ROCK — The University of Arkansas for Medical Sciences has selected Laura B. Dunn, M.D., as the next chair of the Department of Psychiatry in the UAMS College of Medicine and director of the Psychiatric Research Institute.
November 1, 2021
Padala to Head Baptist Health-UAMS Psychiatry Residency Program
![Dr. Prasad Padala](https://news.uams.edu/wp-content/uploads/2021/11/Padala-150x150.jpg)
LITTLE ROCK — Prasad Padala, M.D., M.S., FACHE, a professor in the University of Arkansas for Medical Sciences (UAMS) Department of Psychiatry, has accepted the position of program director of UAMS’ new collaborative psychiatry residency program with Baptist Health.
NIH Awards $13.8 Million to Test UAMS-Discovered Drug for Methamphetamine Use Disorder Treatment
![UAMS’ Brooks Gentry, M.D., is leading the study of what could become the first monoclonal antibody treatment for methamphetamine use disorder and overdose.](https://news.uams.edu/wp-content/uploads/2021/11/Gentry_Brooks-Meth-Study-10252021-EDL_8754-2-crop3-150x150.jpg)
A drug discovered at the University of Arkansas for Medical Sciences (UAMS) to counter the effects of methamphetamine will be tested in a phase 2 clinical trial as the only potential treatment of its kind for methamphetamine use disorder.
October 27, 2021
22nd Annual Geriatrics Update Examines Key Topics: Herbal Supplements, CBD, COPD, COVID
![22nd Annual Geriatric Update](https://news.uams.edu/wp-content/uploads/2021/10/GeriatricUpdateFourSquare-150x150.jpg)
When a patient is asked what prescription or over-the-counter drugs they are taking, they seldom include plant-based dietary supplements, even though these supplements can interact and even counteract other medications.
October 26, 2021
NCI Grant Supporting UAMS Research to Improve Cancer Treatment for Patients Lacking Good Gut Bacteria
![UAMS’ Ruud P.M. Dings, Ph.D., hopes to improve treatment outcomes for cancer patients with an absence of good gut bacteria.](https://news.uams.edu/wp-content/uploads/2021/10/Ruud-Dings-PhD-in-Cancer-lab-09292021-850_5254-150x150.jpg)
LITTLE ROCK — A University of Arkansas for Medical Sciences (UAMS) research team will use a National Cancer Institute (NCI) grant to study promising new ways to improve the effectiveness of a common cancer treatment for patients lacking beneficial gut bacteria. The five-year, nearly $2 million grant is led by Ruud P.M. Dings, Ph.D., M.Sc., an…
October 25, 2021
Oncologist Sindhu Malapati, M.D., Joins UAMS Winthrop P. Rockefeller Cancer Institute
![Sindhu Malapati, M.D., Medical Oncologist specializing in breast cancer](https://news.uams.edu/wp-content/uploads/2021/10/Malapati_Sindhu-Janarthanam_wide-150x150.jpg)
Sindhu Malapati, M.D., has joined the breast team in the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS), where she is treating patients with breast cancer. “Dr. Malapati is a great addition to our team at an important time in the Cancer Institute’s growth,” said Michael Birrer, Winthrop P. …
Previous page Next page